Cytosorbents
CTSO | NASDAQ
$4.85
-$0.02 (-0.41%)
At close: Nov 16, 2026, 4:00 PM ET
$4.85
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.41%
(1D)No price chart data available for 1D timeframe.
Rating
39.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #540/1021 (Top 53%)
Key Statistics
Market Data
Market Cap $15.28M
1D Range
4.46 4.85
52W Range
3.06 16.74
Valuation (TTM)
PE -0.91
PB -6.62
EV/EBITDA -3.38
Valuation (NTM)
Forward PE 15.48
Forward PEG -0.03
Price Target $5.38
Cash Flow
FCF Yield -53.1%
SBC Adj. FCF Yield -70.5%
SBC Impact -32.8%
Margins
Gross Margin 72.9%
Operating Margin -28.6%
FCF Margin -21.7%
Growth (CAGR)
Revenue 3Y | 5Y 1.3% |
-2.4%
Dil EPS 3Y | 5Y 17.1% |
37.4%
FCF 3Y | 5Y 44.3% |
35.6%
Returns
ROA -45.4%
ROE -1340.0%
ROIC -39.3%
Financial Health
Net Debt
$13.32M
Current Ratio 0.55
Interest Coverage -6.50
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorben...
Sector Healthcare
Industry Medical - Devices
Employees 129
IPO Date Aug 8, 2006
Website www.cytosorbents.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.58
Beat +35.56%
YoY:
-1350.00% REV
$9.73M
Miss -1.74%
YoY:
+2.56%Next Earnings
Mar 24, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$10.00
Upside
+106.19%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CTSO